Stroke after coronary artery bypass surgery with and without cardiopulmonary bypass

Javed Iqbal1, Abdul Ghaffar, Ahmad Shahbaz

  • 1Punjab Institute of Cardiology, Lahore, Pakistan. aw_3989@yahoo.com

Insights

Off-pump coronary artery bypass grafting (CABG) significantly reduces stroke incidence compared to on-pump CABG. This approach offers improved patient outcomes by minimizing complications associated with extracorporeal circulation.

Area of Science:

  • Cardiovascular Surgery
  • Neurology
  • Surgical Outcomes

Background:

  • Stroke is a severe complication following coronary artery bypass grafting (CABG).
  • Extracorporeal circulation used in conventional on-pump CABG may contribute to adverse neurological events.
  • Investigating alternative surgical techniques is crucial for improving patient safety.

Purpose of the Study:

  • To evaluate the incidence of stroke in patients undergoing off-pump coronary artery bypass grafting (OPCAB) versus conventional on-pump CABG.
  • To compare the rates of other adverse outcomes, such as renal failure and myocardial infarction, between the two surgical methods.

Main Methods:

  • A randomized controlled trial was conducted involving 200 patients undergoing CABG.
  • Patients were divided into two groups: 100 in the on-pump group (Group A) and 100 in the off-pump group (Group B).
  • Data on stroke, renal failure, myocardial infarction, and mortality were collected and analyzed within 30 days postoperatively.

Main Results:

  • The off-pump CABG group showed a significantly lower incidence of stroke (1.5%) compared to the on-pump group (3.5%).
  • Mortality after stroke within 30 days was 0% in the off-pump group versus 1.5% in the on-pump group.
  • While renal failure was lower in the off-pump group (10% vs. 21%), acute myocardial infarction was higher (11% vs. 2%).

Conclusions:

  • Off-pump CABG is associated with a significantly reduced rate of stroke compared to on-pump CABG.
  • OPCAB may offer a safer alternative for patients at risk of neurological complications during coronary revascularization.
  • Further research may explore optimizing OPCAB to mitigate other potential adverse events.
Abstract